We are live on ! Find out more
BCM

Bayesian Capital Management Portfolio holdings

AUM $81.9M
1-Year Est. Return 26.59%
This Fund
S&P 500
This Quarter Est. Return
+10.93%
1 Year Est. Return
+26.59%
3 Year Est. Return
+112.98%
5 Year Est. Return
+129.77%
10 Year Est. Return
+1,146.62%
AUM
$1.05B
AUM Growth
+$104M
Cap. Flow
+$38.7M
Cap. Flow %
3.7%
Top 10 Hldgs %
11.27%
Holding
1,199
New
495
Increased
134
Reduced
117
Closed
452

Top Buys

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$15.5M
2
PYPL icon
PayPal
PYPL
+$11.8M
3
CSCO icon
Cisco
CSCO
+$10.9M
4
CVX icon
Chevron
CVX
+$9.4M
5
GM icon
General Motors
GM
+$9.39M

Top Sells

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$26.6M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$21.5M
3
MSFT icon
Microsoft
MSFT
+$18.2M
4
BABA icon
Alibaba
BABA
+$16.9M
5
CVS icon
CVS Health
CVS
+$13.5M

Sector Composition

Rank Sector Weight
1 Technology 24.4%
2 Consumer Discretionary 13.2%
3 Financials 11.72%
4 Healthcare 11.25%
5 Industrials 9.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NTLA icon
551
Intellia Therapeutics
NTLA
$1.5B
$303K 0.03%
+11,001
New +$306K
HR icon
552
Healthcare Realty
HR
$7.56B
$301K 0.03%
+21,300
New +$321K
CSGS
553
DELISTED
CSG Systems International
CSGS
$298K 0.03%
+5,785
New +$301K
PRO
554
DELISTED
PROS Holdings
PRO
$298K 0.03%
+8,200
New +$290K
TXT icon
555
Textron
TXT
$14.9B
$297K 0.03%
+3,100
New +$268K
JEF icon
556
Jefferies Financial Group
JEF
$12.6B
$294K 0.03%
+6,661
New +$277K
FATE icon
557
Fate Therapeutics
FATE
$267M
$292K 0.03%
39,800
+20,164
+103% +$125K
BEAM icon
558
Beam Therapeutics
BEAM
$2.67B
$291K 0.03%
+8,803
New +$274K
FN icon
559
Fabrinet
FN
$14.5B
$290K 0.03%
+1,536
New +$308K
ARHS icon
560
Arhaus
ARHS
$1.08B
$290K 0.03%
+18,860
New +$243K
ELME
561
Elme Communities
ELME
$142M
$290K 0.03%
20,839
+9,500
+84% +$132K
LNT icon
562
Alliant Energy
LNT
$18.7B
$289K 0.03%
+5,726
New +$281K
CARG icon
563
CarGurus
CARG
$3.36B
$288K 0.03%
12,487
-28,213
-69% -$653K
LTH icon
564
Life Time Group Holdings
LTH
$10.2B
$288K 0.03%
18,544
+7,600
+69% +$106K
ED icon
565
Consolidated Edison
ED
$41.4B
$287K 0.03%
+3,158
New +$283K
VALE icon
566
Vale
VALE
$62.1B
$286K 0.03%
23,500
-133,000
-85% -$1.8M
FIBK icon
567
First Interstate BancSystem
FIBK
$3.68B
$286K 0.03%
+10,500
New +$287K
BRSL
568
Brightstar Lottery PLC
BRSL
$1.89B
$285K 0.03%
+12,600
New +$316K
LBTYK icon
569
Liberty Global Class C
LBTYK
$3.48B
$284K 0.03%
16,100
-12,100
-43% -$233K
NVTS icon
570
Navitas Semiconductor
NVTS
$2.63B
$284K 0.03%
+59,500
New +$349K
J icon
571
Jacobs Solutions
J
$16.2B
$282K 0.03%
+2,215
New +$260K
AAON icon
572
Aaon
AAON
$7.01B
$281K 0.03%
+3,194
New +$250K
VRE
573
DELISTED
Veris Residential
VRE
$281K 0.03%
18,446
-3,100
-14% -$46.9K
SMPL icon
574
Simply Good Foods
SMPL
$933M
$278K 0.03%
+8,163
New +$301K
ADT icon
575
ADT
ADT
$5.4B
$278K 0.03%
+41,300
New +$274K

Similar funds

Bayesian Capital Management's Q1 2024 Portfolio in Review

As of Q1 2024, Bayesian Capital Management held 1,199 positions worth $1.05B, up 11% from $942M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Bayesian Capital Management deployed $38.7M of net new capital in Q1 2024, opening 495 new positions and adding to 134 existing holdings. Its largest new stake was Oracle: 135,773 shares worth $17.1M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Qualcomm, an estimated $26.6M trimmed.

  • Bayesian Capital Management's largest Q1 2024 buy was Oracle: 135,773 shares worth $17.1M.
  • Bayesian Capital Management added most to Chevron in Q1 2024, an estimated $9.4M increase.
  • Bayesian Capital Management's biggest Q1 2024 reduction was Qualcomm, cutting an estimated $26.6M.
  • Bayesian Capital Management fully exited State Street SPDR S&P 500 ETF Trust in Q1 2024, selling an estimated $21.5M.
  • Bayesian Capital Management's ten largest holdings make up 11% of its $1.05B portfolio in Q1 2024.
  • Bayesian Capital Management opened 495 new positions and closed 452 in Q1 2024.
  • Bayesian Capital Management's portfolio value rose 11% quarter-over-quarter to $1.05B.

Based on Bayesian Capital Management's 13F filing for Q1 2024, filed 15 May 2024.